Reidentification and antifungal susceptibility profile of Candida guilliermondii and Candida famata clinical isolates from a culture collection in Argentina

Medical Mycology

Volumn 57, Issue 3, 2019, Pages 314-323

  Taverna, Constanza Giselle ^a   Córdoba, Susana ^a   Vivot, Matías ^a   Szusz, Wanda ^a   Vivot, Walter ^a   Bosco Borgeat, María Eugenia ^a   Davel, Graciela ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

Author keywords

Debaryomyces; MALDI TOF MS; Meyerozyma; Sequencing; Yeasts molecular identification

Indexed keywords

ANTIFUNGAL AGENT; RIBOSOME DNA; FUNGAL DNA; RIBOSOMAL SPACER DNA;

ANTIFUNGAL SUSCEPTIBILITY; ARGENTINA; ARTICLE; CANDIDA CARPOPHILA; CANDIDA FERMENTATI; DEBARYOMYCES; DEBARYOMYCES FABRYI; DEBARYOMYCES HANSENII; DEBARYOMYCES NEPALENSIS; DEBARYOMYCES TYROCOLA; DNA SEQUENCE; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GENE SEQUENCE; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEYEROZYMA GUILLIERMONDII; NONHUMAN; PHENOTYPE; SEQUENCE ANALYSIS; BIOBANK; CANDIDA; CANDIDIASIS; CLASSIFICATION; DRUG EFFECT; GENETICS; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTIFUNGAL AGENTS; ARGENTINA; BIOLOGICAL SPECIMEN BANKS; CANDIDA; CANDIDIASIS; DEBAROMYCES; DNA, FUNGAL; DNA, RIBOSOMAL; DNA, RIBOSOMAL SPACER; HUMANS; MICROBIAL SENSITIVITY TESTS; SEQUENCE ANALYSIS, DNA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 85062383414     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myy038     Document Type: Article

References (43)

1. Pfaller MA, Diekema DJ, Mendez M et al. Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program. J Clin Microbiol. 2006; 44: 3551-3556.
2. Pfaller MA, Diekema DJ, Gibbs DL et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol. 2010; 48: 1366-1377.
3. Córdoba S, Vivot W, Bosco-Borgeat ME et al. Species distribution and susceptibility profile of yeasts isolated from blood cultures: results of a multicenter active laboratory-based surveillance study in Argentina. Rev Argent Microbiol. 2011; 43: 176-185.
4. Savini V, Catavitello C, Onofrillo D et al. What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast. Mycoses. 2011; 54: 434-441.
5. Miceli MH, Díaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis. 2011; 11: 142-151.
6. Pfaller MA, Andes DR, Diekema DJ et al. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008. PloS One. 2014; 9: e101510.
7. Espinel-Ingroff A, Alvarez-Fernandez M, Cantón E et al. Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method. Antimicrob Agents Chemother. 2015; 59: 6725-6732.
8. Pincus DH, Orenga S, Chatellier S. Yeast identification: past, present, and future methods. Med Mycol. 2007; 45: 97-121.
9. Taverna CG, Bosco-Borgeat ME, Murisengo OA et al. Comparative analyses of classical phenotypic method and ribosomal RNA gene sequencing for identification of medically relevant Candida species. Mem Inst Oswaldo Cruz. 2013; 108: 178-185.
10. Cendejas-Bueno E, Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M. Identification of pathogenic rare yeast species in clinical samples: comparison between phenotypical and molecular methods. J Clin Microbiol. 2010; 48: 1895-1899.
11. Desnos-Ollivier M, Ragon M, Robert V, Raoux D, Gantier J-C, Dromer F. Debaryomyces hansenii (Candida famata), a rare human fungal pathogen often misidentified as Pichia guilliermondii (Candida guilliermondii). J Clin Microbiol. 2008; 46: 3237-3242.
12. Castanheira M, Woosley LN, Diekema DJ, Jones RN, Pfaller MA. Candida guilliermondii and other species of Candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillance programs. J Clin Microbiol. 2013; 51: 117-124.
13. Kim SH, Shin JH, Mok JH et al. Misidentification of Candida guilliermondii as C. famata among strains isolated from blood cultures by the VITEK 2 system. BioMed Res Int. 2014; 2014: 250408.
14. Brandt ME, Lockhart SR. Recent taxonomic developments with Candida and other opportunistic yeasts. Curr Fungal Infect Rep. 2012; 6: 170-177.
15. Vaughan-Martini A, Kurtzman CP, Meyer SA, O'Neill EB. Two new species in the Pichia guilliermondii clade: Pichia caribbica sp. nov., the ascosporic state of Candida fermentati, and Candida carpophila comb. nov. FEMS Yeast Res. 2005; 5: 463-469.
16. Groenewald M, Daniel H-M, Robert V, Poot GA, Smith MT. Polyphasic reexamination of Debaryomyces hansenii strains and reinstatement of D. hansenii, D. fabryi and D. subglobosus. Persoonia. 2008; 21: 17-27.
17. Jacques N, Mallet S, Casaregola S. Delimitation of the species of the Debaryomyces hansenii complex by intron sequence analysis. Int J Syst Evol Microbiol. 2009; 59: 1242-1251.
18. Nguyen H-V, Gaillardin C, Neuvéglise C. Differentiation of Debaryomyces hansenii and Candida famata by rRNA gene intergenic spacer fingerprinting and reassessment of phylogenetic relationships among D. hansenii, C. famata, D. fabryi, C. flareri (= D. subglobosus) and D. prosopidis: description of D. vietnamensis sp. nov. closely related to D. nepalensis. FEMS Yeast Res. 2009; 9: 641-662.
19. Lopandic K, Rentsendorj U, Prillinger H, Sterflinger K. Molecular characterization of the closely related Debaryomyces species: proposition of D. vindobonensis sp. nov. from a municipal wastewater treatment plant. J Gen Appl Microbiol. 2013; 59: 49-58.
20. Vlek A, Kolecka A, Khayhan K et al. Interlaboratory comparison of sample preparation methods, database expansions, and cutoff values for identification of yeasts by matrix-assisted laser desorption ionization-time of flight mass spectrometry using a yeast test panel. J Clin Microbiol. 2014; 52: 3023-3029.
21. Taverna CG, Mazza M, Refojo N, Davel G. A comprehensive analysis of MALDITOF MS and ribosomal DNA sequencing for identification of clinical yeasts. Curr Fungal Infect Rep. 2017; 11: 184-189.
22. Kurtzman CP, Fell JW, Boekhout T. The Yeasts: A Taxonomic Study. London: Elsevier, 2011.
23. Fukuda K, Jin-Shan C, Kawano M, Sudo K, Gunge N. Stress responses of linear plasmids from Debaryomyces hansenii. FEMS Microbiol Lett. 2004; 237: 243-248.
24. Arendrup MC, Meletiadis J, Mouton JW et al. EUCAST DEFINITIVE DOCUMENT E.DEF 7.3.1. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts. January 2017.
25. European Committee on Antimicrobial Susceptibility Testing. Fluconazole: Rationale for the clinical breakpoints, version 2.0, 2013. http://www.eucast.org.
26. European Committee on Antimicrobial Susceptibility Testing. Itraconazole and Candida spp.: Rationale for the clinical breakpoints, version 1.0, 2014. http://www.eucast.org.
27. European Committee on Antimicrobial Susceptibility Testing. Posaconazole: Rationale for the clinical breakpoints, version 2.0, 2016. http://www.eucast.org.
28. Cheng J-W, Yu S-Y, Xiao M et al. Identification and antifungal susceptibility profile of Candida guilliermondii and Candida fermentati from a multicenter study in China. J Clin Microbiol. 2016; 54: 2187-2189.
29. Schoch CL, Seifert KA, Huhndorf S et al. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Proc Natl Acad Sci U S A. 2012; 109: 6241-6246.
30. Irinyi L, Serena C, Garcia-Hermoso D et al. International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database: the quality controlled standard tool for routine identification of human and animal pathogenic fungi. Med Mycol. 2015; 53: 313-337.
31. Daniel H-M, Meyer W. Evaluation of ribosomal RNA and actin gene sequences for the identification of ascomycetous yeasts. Int J Food Microbiol. 2003; 86: 61-78.
32. Chao Q-T, Lee T-F, Teng S-H et al. Comparison of the accuracy of two conventional phenotypic methods and two MALDI-TOF MS systems with that of DNA sequencing analysis for correctly identifying clinically encountered yeasts. PloS One. 2014; 9: e109376.
33. Kim T-H, Kweon OJ, Kim HR, Lee M-K. Identification of Uncommon Candida Species Using Commercial Identification Systems. J Microbiol Biotechnol. 2016; 26: 2206-2213.
34. Pinto A, Halliday C, Zahra M et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry identification of yeasts is contingent on robust reference spectra. PloS One. 2011; 6: e25712.
35. Pence MA, McElvania TeKippe E, Wallace MA, Burnham CA. Comparison and optimization of two MALDI-TOF MS platforms for the identification of medically relevant yeast species. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2014; 33: 1703-1712.
36. Nakase T, Suzuki M. Taxonomic studies on Debaryomyces hansenii (Zopf) Lodder et Kreger-van Rij and related species. II. Practical discrimination and nomenclature. J Gen Appl Microbiol. 1985; 31: 71-86.
37. Rivas P, Pemán J, Córdoba S, Melhem M, de SC. Clinical-Diagnostic Approach To Invasive Fungal Disease. 1st edn. Bogotá, Colombia: Pfizer S.A.S., 2014 [in Spanish].
38. Moretti A, Fukushima K, Takizawa K et al. First report of oral colonization by Debaryomyces nepalensis in a dog. Mycopathologia. 2007; 164: 189-192.
39. Dudiuk C, Macedo D, Leonardelli F et al. Molecular confirmation of the relationship between Candida guilliermondii Fks1p naturally occurring amino acid substitutions and its intrinsic reduced echinocandin susceptibility. Antimicrob Agents Chemother. 2017; 61: e02644-16.
40. Lockhart SR, Messer SA, Pfaller MA, Diekema DJ. Identification and susceptibility profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolates. J Clin Microbiol. 2009; 47: 242-244.
41. Neufeld PM, Melhem M, de SC, Szeszs MW et al. Nosocomial candidiasis in Rio de Janeiro State: distribution and fluconazole susceptibility profile. Braz J Microbiol Publ Braz Soc Microbiol. 2015; 46: 477-484.
42. Subramanya SH, Sharan NK, Baral BP et al. Diversity, in vitro virulence traits and antifungal susceptibility pattern of gastrointestinal yeast flora of healthy poultry, Gallus gallus domesticus. BMC Microbiol. 2017; 17: 113.
43. Brilhante RSN, da Silva AL, Monteiro FOB et al. Yeasts from Scarlet ibises (Eudocimus ruber): a focus on monitoring the antifungal susceptibility of Candida famata and closely related species. Med Mycol. 2017; 55: 725-732.